Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Jan. 31, 2024 |
Jan. 31, 2023 |
Jan. 31, 2024 |
Jan. 31, 2023 |
|||
| Income Statement [Abstract] | ||||||
| Total revenue | $ 3,329,247 | $ 3,332,555 | $ 11,262,898 | $ 11,765,774 | | |
| Cost of goods sold (exclusive of depreciation and amortization, shown separately below) | 2,542,724 | 2,595,093 | 8,713,060 | 9,381,120 | | |
| Operating expenses | 568,908 | 515,735 | 1,709,466 | 1,598,213 | | |
| Depreciation and amortization | 88,950 | 78,088 | 257,453 | 232,500 | | |
| Interest, net | 14,146 | 11,697 | 38,947 | 39,015 | | |
| Total Other Expenses | 3214728.0 | 3200613.0 | 10718926.0 | 11250848.0 | 0 | |
| Income before income taxes | 114,519 | 131,942 | 543,972 | 514,926 | | |
| Federal and state income taxes | 27,586 | 31,830 | 129,020 | 124,327 | | |
| Net income | $ 86,933 | $ 100,112 | $ 414,952 | $ 390,599 | | |
| Net income per common share | ||||||
| Basic (in dollars per share) | $ 2.34 | $ 2.69 | $ 11.15 | $ 10.48 | ||
| Diluted (in dollars per share) | $ 2.33 | $ 2.67 | $ 11.09 | $ 10.42 | ||
| Basic weighted average shares outstanding (in shares) | 37,100,143 | 37,281,103 | 37,210,007 | 37,261,049 | ||
| Plus effect of stock compensation (in shares) | 235,940 | 283,448 | 199,531 | 240,459 | ||
| Diluted weighted average shares outstanding (in shares) | 37,336,083 | 37,564,551 | 37,409,538 | 37,501,508 | ||
| Dividends declared per share (in dollars per share) | $ 0.43 | $ 0.38 | $ 1.29 | $ 1.14 | ||
| X | ||||||||||
- Definition Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|